The effect of protein deficiency on growth and response of primary and metastatic hepatoma

Thomas R. Weber, Michael Dalsing, Alan Sawchuck, Paul Sieber, Jay L. Grosfeld

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Although protein-energy malnutrition is common in the cancer patient, the efficacy of aggressive nutritional therapy is unclear. This study evaluates the effects of protein deficiency on tumor growth, response, and chemotherapy complications in primary and metastatic rat hepatoma. Seventy-two ACI rats (200-250 g) with implanted Morris hepatoma were divided into four groups (N = 18 for each group): 1, regular diet; 2, regular diet plus cyclophosphamide (CPM) (100 mg/kg/ip); 3, protein-free diet; and 4, protein-free diet + CPM. Forty additional rats in similar groups (5-8, ten in each group) underwent intravenous injection of 6 × 103 tumor cells to produce pulmonary metastases. Animals were assessed for survival, tumor size, serum albumin, number of pulmonary metastases, and hemorrhagic cystitis at 2 weeks. Survival was 50% in groups 4 and 8, and 100% in the others. Serum albumin was significantly lower in rats on protein free diets (2.59 ± 0.37 vs 3.35 ± 0.40 g%, P < 0.01). Tumor volume was significantly reduced by CPM (26.0 ± 4.2 cm3 vs 1.2 ± 0.4 cm3, P < 0.01). Protein-free diets resulted in lower total body weight, and reduced tumor volume without, but not with CPM (14 ± 1.6 cm3P < 0.05, 1.1 ± 0.3 cm3, P < 0.05 vs above controls). CPM reduced the number of pulmonary metastases in regular diet groups (307.2 ± 108.3 vs 36 ± 11, P < 0.01), while protein free diets did not significantly affect metastases, without or with CPM (251.7 ± 71.4 and 22.3 ± 12.4, P > 0.05 vs controls). Hemorrhagic cystitis was much more common in protein free groups compared to rats on regular diets (55 vs 11%, P < 0.01). These data indicate that protein deficiency did not affect response to chemotherapy in a primary or metastatic rat hepatoma model. However, protein deficiency results in a significantly increased rate of mortality, weight loss, and hemorrhagic cystitis which may lead to delay or cessation of cancer therapy.

Original languageEnglish
Pages (from-to)395-403
Number of pages9
JournalJournal of Surgical Research
Volume34
Issue number5
DOIs
StatePublished - 1983

Fingerprint

Protein Deficiency
Hepatocellular Carcinoma
Protein-Restricted Diet
Cystitis
Growth
Neoplasms
Diet
Serum Albumin
Cyclophosphamide
Inbred ACI Rats
Experimental Liver Neoplasms
Neoplasm Metastasis
Drug Therapy
Protein-Energy Malnutrition
Lung
Survival
Intravenous Injections
Weight Loss
Mortality
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

The effect of protein deficiency on growth and response of primary and metastatic hepatoma. / Weber, Thomas R.; Dalsing, Michael; Sawchuck, Alan; Sieber, Paul; Grosfeld, Jay L.

In: Journal of Surgical Research, Vol. 34, No. 5, 1983, p. 395-403.

Research output: Contribution to journalArticle

Weber, Thomas R. ; Dalsing, Michael ; Sawchuck, Alan ; Sieber, Paul ; Grosfeld, Jay L. / The effect of protein deficiency on growth and response of primary and metastatic hepatoma. In: Journal of Surgical Research. 1983 ; Vol. 34, No. 5. pp. 395-403.
@article{f7c55ffd8cb44279ad99261b778dcff9,
title = "The effect of protein deficiency on growth and response of primary and metastatic hepatoma",
abstract = "Although protein-energy malnutrition is common in the cancer patient, the efficacy of aggressive nutritional therapy is unclear. This study evaluates the effects of protein deficiency on tumor growth, response, and chemotherapy complications in primary and metastatic rat hepatoma. Seventy-two ACI rats (200-250 g) with implanted Morris hepatoma were divided into four groups (N = 18 for each group): 1, regular diet; 2, regular diet plus cyclophosphamide (CPM) (100 mg/kg/ip); 3, protein-free diet; and 4, protein-free diet + CPM. Forty additional rats in similar groups (5-8, ten in each group) underwent intravenous injection of 6 × 103 tumor cells to produce pulmonary metastases. Animals were assessed for survival, tumor size, serum albumin, number of pulmonary metastases, and hemorrhagic cystitis at 2 weeks. Survival was 50{\%} in groups 4 and 8, and 100{\%} in the others. Serum albumin was significantly lower in rats on protein free diets (2.59 ± 0.37 vs 3.35 ± 0.40 g{\%}, P < 0.01). Tumor volume was significantly reduced by CPM (26.0 ± 4.2 cm3 vs 1.2 ± 0.4 cm3, P < 0.01). Protein-free diets resulted in lower total body weight, and reduced tumor volume without, but not with CPM (14 ± 1.6 cm3P < 0.05, 1.1 ± 0.3 cm3, P < 0.05 vs above controls). CPM reduced the number of pulmonary metastases in regular diet groups (307.2 ± 108.3 vs 36 ± 11, P < 0.01), while protein free diets did not significantly affect metastases, without or with CPM (251.7 ± 71.4 and 22.3 ± 12.4, P > 0.05 vs controls). Hemorrhagic cystitis was much more common in protein free groups compared to rats on regular diets (55 vs 11{\%}, P < 0.01). These data indicate that protein deficiency did not affect response to chemotherapy in a primary or metastatic rat hepatoma model. However, protein deficiency results in a significantly increased rate of mortality, weight loss, and hemorrhagic cystitis which may lead to delay or cessation of cancer therapy.",
author = "Weber, {Thomas R.} and Michael Dalsing and Alan Sawchuck and Paul Sieber and Grosfeld, {Jay L.}",
year = "1983",
doi = "10.1016/0022-4804(83)90088-4",
language = "English",
volume = "34",
pages = "395--403",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - The effect of protein deficiency on growth and response of primary and metastatic hepatoma

AU - Weber, Thomas R.

AU - Dalsing, Michael

AU - Sawchuck, Alan

AU - Sieber, Paul

AU - Grosfeld, Jay L.

PY - 1983

Y1 - 1983

N2 - Although protein-energy malnutrition is common in the cancer patient, the efficacy of aggressive nutritional therapy is unclear. This study evaluates the effects of protein deficiency on tumor growth, response, and chemotherapy complications in primary and metastatic rat hepatoma. Seventy-two ACI rats (200-250 g) with implanted Morris hepatoma were divided into four groups (N = 18 for each group): 1, regular diet; 2, regular diet plus cyclophosphamide (CPM) (100 mg/kg/ip); 3, protein-free diet; and 4, protein-free diet + CPM. Forty additional rats in similar groups (5-8, ten in each group) underwent intravenous injection of 6 × 103 tumor cells to produce pulmonary metastases. Animals were assessed for survival, tumor size, serum albumin, number of pulmonary metastases, and hemorrhagic cystitis at 2 weeks. Survival was 50% in groups 4 and 8, and 100% in the others. Serum albumin was significantly lower in rats on protein free diets (2.59 ± 0.37 vs 3.35 ± 0.40 g%, P < 0.01). Tumor volume was significantly reduced by CPM (26.0 ± 4.2 cm3 vs 1.2 ± 0.4 cm3, P < 0.01). Protein-free diets resulted in lower total body weight, and reduced tumor volume without, but not with CPM (14 ± 1.6 cm3P < 0.05, 1.1 ± 0.3 cm3, P < 0.05 vs above controls). CPM reduced the number of pulmonary metastases in regular diet groups (307.2 ± 108.3 vs 36 ± 11, P < 0.01), while protein free diets did not significantly affect metastases, without or with CPM (251.7 ± 71.4 and 22.3 ± 12.4, P > 0.05 vs controls). Hemorrhagic cystitis was much more common in protein free groups compared to rats on regular diets (55 vs 11%, P < 0.01). These data indicate that protein deficiency did not affect response to chemotherapy in a primary or metastatic rat hepatoma model. However, protein deficiency results in a significantly increased rate of mortality, weight loss, and hemorrhagic cystitis which may lead to delay or cessation of cancer therapy.

AB - Although protein-energy malnutrition is common in the cancer patient, the efficacy of aggressive nutritional therapy is unclear. This study evaluates the effects of protein deficiency on tumor growth, response, and chemotherapy complications in primary and metastatic rat hepatoma. Seventy-two ACI rats (200-250 g) with implanted Morris hepatoma were divided into four groups (N = 18 for each group): 1, regular diet; 2, regular diet plus cyclophosphamide (CPM) (100 mg/kg/ip); 3, protein-free diet; and 4, protein-free diet + CPM. Forty additional rats in similar groups (5-8, ten in each group) underwent intravenous injection of 6 × 103 tumor cells to produce pulmonary metastases. Animals were assessed for survival, tumor size, serum albumin, number of pulmonary metastases, and hemorrhagic cystitis at 2 weeks. Survival was 50% in groups 4 and 8, and 100% in the others. Serum albumin was significantly lower in rats on protein free diets (2.59 ± 0.37 vs 3.35 ± 0.40 g%, P < 0.01). Tumor volume was significantly reduced by CPM (26.0 ± 4.2 cm3 vs 1.2 ± 0.4 cm3, P < 0.01). Protein-free diets resulted in lower total body weight, and reduced tumor volume without, but not with CPM (14 ± 1.6 cm3P < 0.05, 1.1 ± 0.3 cm3, P < 0.05 vs above controls). CPM reduced the number of pulmonary metastases in regular diet groups (307.2 ± 108.3 vs 36 ± 11, P < 0.01), while protein free diets did not significantly affect metastases, without or with CPM (251.7 ± 71.4 and 22.3 ± 12.4, P > 0.05 vs controls). Hemorrhagic cystitis was much more common in protein free groups compared to rats on regular diets (55 vs 11%, P < 0.01). These data indicate that protein deficiency did not affect response to chemotherapy in a primary or metastatic rat hepatoma model. However, protein deficiency results in a significantly increased rate of mortality, weight loss, and hemorrhagic cystitis which may lead to delay or cessation of cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=0020615186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020615186&partnerID=8YFLogxK

U2 - 10.1016/0022-4804(83)90088-4

DO - 10.1016/0022-4804(83)90088-4

M3 - Article

C2 - 6843109

AN - SCOPUS:0020615186

VL - 34

SP - 395

EP - 403

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 5

ER -